What is NDC 0264-7730?

0264-7730 is the product NDC for Isolyte P in Dextrose, Dextrose monohydrate 5 g/100mL + 4 more ingredients injection, solution, listed with the FDA by B. Braun Medical Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Isolyte P in Dextrose (Dextrose, Sodium Acetate, Potassium Chloride, Magnesium Chloride, and Potassium Phosphate, Dibasic).

What is the active ingredient?

Dextrose monohydrate, Sodium acetate, Potassium chloride, Magnesium chloride, Potassium phosphate, Dibasic.

B. Braun Medical Inc., NDC labeler code 0264. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Isolyte P in Dextrose?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Isolyte P in Dextrose NDC 0264-7730

NDC codes

FDA NDC Directory

Product NDC (as listed)0264-7730Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00264-7730Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0264-7730-10	0026477301000264773010	24 CONTAINER in 1 CASE (0264-7730-10) / 500 mL in 1 CONTAINERMarketed from Jun 10, 1993

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Isolyte P in Dextrose
Generic name (nonproprietary): dextrose, sodium acetate, potassium chloride, magnesium chloride, and potassium phosphate, dibasic
Active ingredients: Dextrose monohydrate — 5 g/100mLSodium acetate — .32 g/100mLPotassium chloride — .13 g/100mLMagnesium chloride — .031 g/100mLPotassium phosphate, Dibasic — .026 g/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: B. Braun Medical Inc.NDC labeler code 0264
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019873
Marketing start: Jun 10, 1993
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 0264-7730_9bdb0637-4e2b-40a0-9fa6-fb2f335561bdSPL ID 9bdb0637-4e2b-40a0-9fa6-fb2f335561bdSPL set ID 4ea4397c-2fa4-4670-91e6-21ae498c88f7RxCUI 800808, 800812UNII LX22YL083G, 4550K0SC9B, 660YQ98I10, 02F3473H9O, CI71S98N1Z
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400264773010 followed by a unit qualifier and the quantity

Package 00264-7730-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 24, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE This solution is indicated for use in adults as a source of electrolytes, calories and water for hydration, and as an alkalinizing agent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0264-7730

What is NDC 0264-7730?: 0264-7730 is the product NDC for Isolyte P in Dextrose, Dextrose monohydrate 5 g/100mL + 4 more ingredients injection, solution, listed with the FDA by B. Braun Medical Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Isolyte P in Dextrose (Dextrose, Sodium Acetate, Potassium Chloride, Magnesium Chloride, and Potassium Phosphate, Dibasic).
What is the active ingredient?: Dextrose monohydrate, Sodium acetate, Potassium chloride, Magnesium chloride, Potassium phosphate, Dibasic.
Who is the labeler?: B. Braun Medical Inc., NDC labeler code 0264. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Isolyte P in Dextrose?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.